129833-52-9

Basic information

• Product Name: N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide
• Synonyms: N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide
• CAS NO: 129833-52-9
• Molecular Weight: 257.087
• Mol File: 129833-52-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide(129833-52-9)
• EPA Substance Registry System: N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide(129833-52-9)

Safety Data

• Hazardous Substances Data: 129833-52-9(Hazardous Substances Data)

Upstream product

• 115-17-3 bromal 
• 55289-36-6 3-bromo-2-methylaniline 
• 55289-35-5 2-bromo-6-nitrotoluene 
• 302-17-0 chloral hydrate 

Downstream Products

• 129833-23-4 (6-Bromo-5-methyl-9-oxo-9H-xanthen-4-yl)-acetic acid 
• 129833-36-9 4-bromo-2-iodo-3-methylbenzoic acid 
• 129833-29-0 2-amino-4-bromo-3-methylbenzoic acid 

Relevant articles and documents

INDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES

The present invention relates to novel Indazole Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, X, Y, Z, R1 R5 and R6 are as defined herein. The present invention also relates to compositions comprising at least one Indazole Derivative, and methods of using the Indazole Derivatives for treating or preventing a herpesvirus infection in a patient.

A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity

-

INDOLINONE ANALOGUES AS BRD4 INHIBITORS

The present invention encompasses compounds of general formula (I) wherein the groups R1 to R4, A1 and A2 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.